Dexanabinol prevents development of vasospasm in the rat femoral artery model
- 7 February 2008
- journal article
- Published by Springer Nature in Neurosurgical Review
- Vol. 31 (2) , 215-223
Abstract
We postulated that a multi-potential agent such as dexanabinol may prevent the development of vasospasm after subarachnoid hemorrhage. We tested the effect of dexanabinol (10 mg/kg) on established vasospasm in a rat femoral artery model. Dexanabinol was given as single or repeated doses. On the 7th day after blood application, vessels were prepared for transmission electron microscopy studies, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling staining, and studying vessel morphology including luminal area and wall thickness. Application of blood to femoral artery caused a significant narrowing of luminal area (p < 0.001) and a marked increase of radial wall thickness (p < 0.001) when compared to controls. Similar to its single injection, repeated doses of dexanabinol markedly widened luminal area (p < 0.001) near to control values (p > 0.05) and decreased radial wall thickness significantly compared to hemorrhage (p < 0.05) and vehicle-treated groups (for single p < 0.05 and repetitive injections p < 0.01). Both single and multiple dexanabinol injections also lowered apoptotic index (p < 0.001). In conclusion, dexanabinol seems to prevent established vasospasm and endothelial cell apoptosis.Keywords
This publication has 49 references indexed in Scilit:
- Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage–induced cerebral vasospasmSurgical Neurology, 2005
- The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-κB)Neuropharmacology, 2004
- Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogsLife Sciences, 2004
- Inhibition of Experimental Vasospasm in Rats With the Periadventitial Administration of Ibuprofen Using Controlled-Release PolymersStroke, 1999
- Monoclonal Antibodies Against ICAM-1 and CD18 Attenuate Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in RabbitsStroke, 1998
- HU-211, a Novel Noncompetitive N -Methyl- d- Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the RatStroke, 1995
- Effect of Remacemide Hydrochloride on Subarachnoid Hemorrhage-Induced Vasospasm in RabbitsJournal of Neurotrauma, 1994
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.Stroke, 1985
- Progress in cerebrovascular disease. Management of cerebral aneurysm.Stroke, 1981